Ali Behbahani

Ali Behbahani

Chairman presso NKARTA, INC.

Patrimonio netto: 800 419 $ in data 31/03/2024

47 anni
Health Technology
Finance
Consumer Services

Profilo

Ali Behbahani is currently the Chairman at Nkarta, Inc. He also holds director positions at Rotation Medical, Inc., Ivantis, Inc., Ocutherix, Inc., CVRx, Inc., CRISPR Therapeutics AG, ClarVista Medical, Inc., Adaptimmune Therapeutics Plc, Cardionomic, Inc., Arcellx, Inc., Black Diamond Therapeutics, Inc., Korro Bio, Inc. (United States), 858 Therapeutics, Inc., Monte Rosa Therapeutics, Inc., Stablix, Inc., Tune Therapeutics, Inc., FirstLight Bio, Inc., SpyGlass Pharma Inc, Launchpad Therapeutics, Inc., and Korro Bio, Inc. (starting in 2023).
His former positions include being a director at Solace Therapeutics, Inc., Genocea Biosciences, Inc. (from 2018 to 2022), Minerva Surgical, Inc., Nevro Corp.
(from 2014 to 2019), Adaptimmune Ltd., Oyster Point Pharma, Inc. (from 2017 to 2023), The Medicines Co. (from 2003 to 2005), Lehman Brothers Asset Management LLC (from 1998 to 2000), and Morgan Stanley Venture Partners (from 2000 to 2002).
Dr. Behbahani received his undergraduate degree from Duke University.
He also holds an MBA from The Wharton School of the University of Pennsylvania and a doctorate from the University of Pennsylvania Medical Center.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
0.07%
22/04/2024 5 332 ( 0.07% ) 479 880 $ 31/03/2024
15/03/2024 51 690 ( 0.10% ) 262 068 $ 31/03/2024
14/06/2023 424 ( 0.00% ) 29 489 $ 31/03/2024
08/06/2023 270 ( 0.00% ) 18 403 $ 31/03/2024
14/12/2023 316 ( 0.00% ) 5 754 $ 31/03/2024
13/06/2023 135 ( 0.00% ) 3 391 $ 31/03/2024
31/03/2023 2 292 ( 0.03% ) 1 433 $ 31/03/2024
15/01/2024 0 ( -.--% ) - $ 31/03/2024
14/06/2023 0 ( -.--% ) - $ 31/03/2024
07/06/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Ali Behbahani

SocietàPosizioneInizio
CRISPR THERAPEUTICS AG Director/Board Member 01/04/2015
ADAPTIMMUNE THERAPEUTICS PLC Director/Board Member 01/09/2014
CVRX, INC. Director/Board Member 01/07/2013
MONTE ROSA THERAPEUTICS, INC. Director/Board Member 01/04/2020
NKARTA, INC. Chairman 01/08/2019
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 01/12/2018
ARCELLX, INC. Director/Board Member 01/02/2015
Private Equity Investor 01/08/2007
Corporate Officer/Principal 01/01/2007
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tutte le posizioni attive di Ali Behbahani

Precedenti posizioni note di Ali Behbahani

SocietàPosizioneFine
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ali Behbahani

Formazione di Ali Behbahani

Duke University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
University of Pennsylvania Medical Center Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ali Behbahani

Relazioni

100 +

Relazioni di 1° grado

33

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa10
GENOCEA BIOSCIENCES, INC.

Health Technology

MINERVA SURGICAL, INC.

Health Technology

CVRX, INC.

Health Technology

NEVRO CORP.

Health Technology

CRISPR THERAPEUTICS AG

Health Technology

ARCELLX, INC.

Health Technology

BLACK DIAMOND THERAPEUTICS, INC.

Health Technology

NKARTA, INC.

Health Technology

MONTE ROSA THERAPEUTICS, INC.

Health Technology

ADAPTIMMUNE THERAPEUTICS PLC

Health Technology

Aziende private20

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Services

Health Technology

Health Services

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

FirstLight Bio, Inc.

Commercial Services

Commercial Services

Vedi le connessioni aziendali